IQVIA Oncology Dynamics (Australia) §
N/A
N/A
To find publications, please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
N/A
N/A
To find publications, please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
The Swedish Arthroplasty Register (SAR) is a National Quality Register. It is a merger of the two oldest national arthroplasty registers, the Swedish Knee Arthroplasty Register and the Swedish Hip Arthroplasty Register, including knee replacements since 1975, hip replacements since 1979, hemiarthroplasties since 2005, and knee osteotomies since 2013. Reoperations, revisions and other procedures, related to the knee or hip are registered, as well as patient-reported outcome(s).
Professor Ola Rolfson
The Swedish Arthroplasty Register
413 45 Gothenburg
SWEDEN
Email: ola.rolfson@vgregion.se
The Swedish Arthroplasty Register
413 45 Gothenburg
SWEDEN
Phone: +46 10 441 29 31
Email: slr@registercentrum.se
1. Jolbäck P, Bedeschi Rego De Mattos C, Rogmark C, Chen AF, Nauclér E, Tsikandylakis G. Patient-reported Outcomes After Primary Total Hip Arthroplasty Are Not Affected by the Sex of the Surgeon: A Register-based Study of 8,383 Procedures in Western Sweden. J Am Acad Orthop Surg. 2023 Jul 1;31(13):692-700.
2. Dale H, Fenstad AM, Hallan G, Overgaard S, Pedersen AB, Hailer NP, Kärrholm J, Rolfson O, Eskelinen A, Mäkelä KT, Furnes O. Increasing risk of revision due to infection after primary total hip arthroplasty: results from the Nordic Arthroplasty Register Association. Acta Orthop. 2023 Jun 27;94:307-315.
3. Gustafsson K, Kvist J, Eriksson M, Rolfson O. What Factors Identified in Initial Osteoarthritis Management Are Associated With Poor Patient-reported Outcomes After THA? A Register-based Study. Clin Orthop Relat Res. 2023 May 9;481(9):1732–42.
4. Itayem R, Rolfson O, Mohaddes M, Kärrholm J. What is the Role of Stem Size and Offset in the Risk of Nonseptic Revision of the Exeter® 150-mm Stem? A Study From the Swedish Arthroplasty Register. Clin Orthop Relat Res. 2023 Apr 28;481(9):1689–99.
5. Ighani Arani P, Wretenberg P, Stenberg E, Ottosson J, W-Dahl A. Total knee arthroplasty and bariatric surgery: change in BMI and risk of revision depending on sequence of surgery. BMC Surg. 2023 Mar 10;23(1):53.
6. Lagergren J, Mukka S, Wolf O, Nauclér E, Möller M, Rogmark C. Conversion to Arthroplasty After Internal Fixation of Nondisplaced Femoral Neck Fractures: Results from a Swedish Register Cohort of 5,428 Individuals 60 Years of Age or Older. J Bone Joint Surg Am. 2023 Mar 1;105(5):389-396.
7. Cöster MC, Bremander A, Nilsdotter A. Patient-reported outcome for 17,648 patients in 5 different Swedish orthopaedic quality registers before and 1 year after surgery: an observational study. Acta Orthop. 2023 Jan 23;94:1-7.
8. Jolbäck P, Mukka S, Wetterling K, Mohaddes M, Garland A. Patient-surgeon sex discordance impacts adverse events but does not affect patient-reported satisfaction after primary total hip arthroplasty: a regional register-based cohort study. Acta Orthop. 2022 Dec 27;93:922–9.
9. Thompson O, W-Dahl A, Stefánsdóttir A. Increased short- and long-term mortality amongst patients with early periprosthetic knee joint infection. BMC Musculoskelet Disord. 2022 Dec 6;23(1):1069.
10. Rönnquist SS, Lagergren J, Viberg B, Möller M, Rogmark C. Rate of conversion to secondary arthroplasty after femoral neck fractures in 796 younger patients treated with internal fixation: a Swedish national register-based study. Acta Orthop. 2022 Jun 14;93:547-553.
Started in 2014, STATinMED’s licensed all-payer medical, and pharmacy claims dataset (STATinMED Real World Data Insights) provides insight into approximately 80% of the US healthcare system. These data are comparable with other all-payer claims repositories as they are sourced directly from claims clearinghouses, which are responsible to manage claims transactions between payers and providers, offering comprehensive coverage at the patient level across the US healthcare system.
Keshia Maughn
SVP/Principal, RWE (STATinMED RWD Insights)
STATinMED, LLC
13101 Preston Rd Suite 110, #3395
Dallas, TX 75240
USA
Phone:+1 214-480-4946
Email: kmaughn@statinmed.com
STATinMED RWD Insights
Amy Rovi, SVP, Sales and Marketing
STATinMED, LLC
13101 Preston Rd Suite 110, #3395
Dallas, TX 75240
USA
Phone: +1 214-480-4946
Email: arovi@statinmed.com
1. Navari RM, Nelson WW, Shoaib S, Singh R, Zhang W, Bailey WL. Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy. Adv Ther. 2023 Jul;40(7):3217-3226.
2. Escobar M, Bullano M, Mokdad AG, Caicedo J, Schultz BG, Fan Q, Verma S. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Expert Rev Hematol. 2023 Jun;16(6):467-474.
3. Terrault N, Dieyi C, Trivedi R, Coppola R, Maynard J, Reau N, Satram S, Chattergoon M. Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States. AASLD The Liver Meeting. Boston, MA: Nov 10-14, 2023.
4. Karlitz J, Liu Y, Gupta P, Aweh G, Chung K. Burden of liver cancer among Medicaid-insured patients: A retrospective analysis of a national all-payer claims database. American College of Gastroenterology (ACG) Annual Scientific Meeting. Vancouver, CA: Oct 20-25, 2023.
5. Holman D, Drayton D, Pandit M, Diaz A, Maughn K, Dieyi C, Achter E, Peeples H. Effects of insurance coverage and antiseizure medication formulary policies on the experiences of patients with epilepsy and healthcare professionals: A qualitative study. Academy of Managed Care Pharmacy (AMCP) Nexus 2023. Orlando, FL: Oct 16-19, 2023.
6. Chung KC, Karlitz J, Liu Y, Gupta P, Aweh G. Cancer incidence among the Medicaid population: A retrospective analysis of a national all-payer claims database. Academy of Managed Care Pharmacy (AMCP) Nexus 2023. Orlando, FL: Oct 16-19, 2023.
7. Hendrix K, Feliciano J, Wassel C, Feld A, Maynard J, Batchu L, Lauterio M, Mohanty M, Dasenbrook E. Real-world disease burden and mortality associated with bronchiectasis. American College of Chest Physicians (CHEST) Annual Meeting. Honolulu, HI: Oct 8-11, 2023.
8. Sarafoglou K, Casteras A, Charlton RW, Barnes C, Dieyi C, Thornton P. Dose dependent risks of glucocorticoid treatment in classic CAH. European Society for Paediatric Endocrinology (ESPE). Hague, Netherlands: Sept 21-23, 2023.
9. Jagannath S, Kharat A, Fu AZ, Huo S, Kohli M, Adams S, Umeh E, Foster M. Healthcare resource utilization and costs among patients with relapsed/refractory multiple myeloma treated with chimeric antigen receptor-T (CAR-T) cell therapy. Annual Meeting of the Society of Hematologic Oncology (SOHO) 2023. Houston, TX: Sept 6-9, 2023.
10. Aksamit T, Wu J, Hassan M, Achter E, Chatterjee A. Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings. BMC Pulm Med. 2022 Dec 3;22(1):461.
- Meet three of our Board members attending ICPE in Halifax;
- It’s our 15th birthday, and you get 15% off your first subscription;
- We are more than just a database resource – we provide database landscaping services;
- Complete a 2-minute survey and tell us how we can better assist you!
Read more in our latest newsletter
The Norwegian Immunisation Registry SYSVAK (national vaccination register) is a nationwide electronic vaccination register established in 1995. Until October 2009, the reporting obligation to SYSVAK only covered vaccines given in the childhood vaccination programme. During the flu pandemic in 2009, reporting was also introduced for the vaccine against pandemic flu. Starting January 2011, the reporting obligation was extended to apply to all vaccinations for all age groups in the population.
Established in October 2011, TURKBIO is the first nationwide biological database contributed by 15 different centers across Turkey. TURKBIO is a registry that allows patients to enter data using electronic touchscreens.
All enquiries regarding the disclosure of health data should be directed to the e-mail address: datatilgang@fhi.no
N/A
1. Dong L, Nygård M, Støer NC, Klungsøyr O, Hansen BT. Real‐world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination. International Journal of Cancer. 2023 Jul 15;153(2):399-406.
2. Nilsen TS, Gulseth HL, Daae A, Indseth T. Coronavirus immunisation abroad among foreign-born persons in Norway. Tidsskrift for Den norske legeforening. 2022 Jun 27.
3. Hagerup-Jenssen M, Kongsrud S, Riise ØR. Suboptimal MMR2 vaccine coverage in six counties in Norway detected through the national immunisation registry, April 2014 to April 2017. Euro Surveill. 2017 Apr 27;22(17):30518.
4. Riise ØR, Laake I, Bergsaker MA, Nøkleby H, Haugen IL, Storsæter J. Monitoring of timely and delayed vaccinations: a nation-wide registry-based study of Norwegian children aged < 2 years. BMC Pediatr. 2015 Nov 13;15:180.
5. Riise O. 1066: Delay in the Norwegian Immunisation Programme. Open Forum Infect Dis. 2014 Dec;1(Suppl 1):S312–3.
6. Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013 Dec 16;31(52):6232-8.
7. Trogstad L, Ung G, Hagerup-Jenssen M, Cappelen I, Haugen IL, Feiring B. The Norwegian immunisation register--SYSVAK. Euro Surveill. 2012 Apr 19;17(16):20147.
8. Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine. 2012 Jan 11;30(3):544-51.
9. Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K. Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. BMC Infect Dis. 2012 Mar 20;12:63.
10. Waalen K, Kilander A, Dudman S G, Krogh G H, Aune T, Hungnes O. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 2010;15(31):pii=19633.